Michael A Barry

Author PubWeight™ 74.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt 2007 3.04
2 Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol 2008 3.01
3 Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther 2007 1.94
4 Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther 2005 1.86
5 Protection of the coronary arteries during epicardial radiofrequency ablation with intracoronary chilled saline irrigation: assessment in an in vitro model. J Cardiovasc Electrophysiol 2006 1.70
6 Characterization of species C human adenovirus serotype 6 (Ad6). Virology 2011 1.59
7 Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Res 2008 1.57
8 Lentiviral vectors: basic to translational. Biochem J 2012 1.49
9 Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 2011 1.42
10 Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther 2003 1.33
11 Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol Ther 2008 1.28
12 Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. PLoS One 2009 1.26
13 Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Mol Ther 2004 1.26
14 Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents. Virology 2009 1.23
15 Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Hum Gene Ther 2009 1.21
16 Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. J Virol 2009 1.18
17 Bipolar ablation of the interventricular septum is more efficient at creating a transmural line than sequential unipolar ablation. Pacing Clin Electrophysiol 2010 1.15
18 Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus. Mol Ther 2009 1.15
19 Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination. Hum Gene Ther 2004 1.15
20 Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. J Virol 2010 1.13
21 Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Virology 2006 1.11
22 Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J Virol 2011 1.09
23 Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. J Virol 2006 1.09
24 Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum Gene Ther 2007 1.08
25 Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine 2007 1.08
26 A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. Proc Natl Acad Sci U S A 2004 1.08
27 Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses. Hum Gene Ther 2008 1.01
28 Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines. Viruses 2009 1.01
29 In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum Gene Ther 2003 1.01
30 Infection and killing of multiple myeloma by adenoviruses. Hum Gene Ther 2010 0.98
31 In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 2005 0.97
32 The role of T cell antagonism and original antigenic sin in genetic immunization. J Immunol 2002 0.96
33 Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect. J Biomed Mater Res A 2006 0.95
34 Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro. J Biomed Mater Res A 2006 0.95
35 Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer. Mol Ther 2011 0.95
36 Targeting adenoviruses with factor x-single-chain antibody fusion proteins. Hum Gene Ther 2010 0.95
37 Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Hum Gene Ther 2011 0.93
38 Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules 2008 0.92
39 Deoxyribonuclease II is a lysosomal barrier to transfection. Mol Ther 2003 0.91
40 Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy. Dis Model Mech 2013 0.91
41 Maximizing antigen targeting to the proteasome for gene-based vaccines. Mol Ther 2004 0.90
42 Circulating antibodies and macrophages as modulators of adenovirus pharmacology. J Virol 2013 0.90
43 A library-selected, Langerhans cell-targeting peptide enhances an immune response. DNA Cell Biol 2004 0.90
44 Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting. J Virol 2005 0.89
45 Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy. Hum Gene Ther 2009 0.88
46 Intramyocardial adiposity after myocardial infarction: new implications of a substrate for ventricular tachycardia. Circulation 2013 0.88
47 Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS One 2011 0.87
48 Comparison of electroanatomic contact and noncontact mapping of ventricular scar in a postinfarct ovine model with intramural needle electrode recording and histological validation. Circ Arrhythm Electrophysiol 2008 0.87
49 Species D adenoviruses as oncolytics against B-cell cancers. Clin Cancer Res 2011 0.86
50 Selection of chronic lymphocytic leukemia binding peptides. Cancer Res 2003 0.85
51 Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. FASEB J 2012 0.83
52 Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PLoS One 2013 0.83
53 Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs. Biomaterials 2004 0.83
54 Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing. Mol Ther 2013 0.82
55 Real-time dynamic imaging of virus distribution in vivo. PLoS One 2011 0.81
56 Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors. Hum Gene Ther 2006 0.81
57 Low seroprevalent species D adenovirus vectors as influenza vaccines. PLoS One 2013 0.81
58 A vector-host system to fingerprint virus tropism. Hum Gene Ther 2012 0.81
59 Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine. J Immunol 2002 0.80
60 Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines. J Immunol 2004 0.80
61 Clinical evaluation of a new technique to monitor return electrode skin temperature during radiofrequency ablation. J Interv Card Electrophysiol 2012 0.79
62 Improved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectors. Exp Eye Res 2006 0.79
63 Rad23 as a reciprocal agent for stimulating or repressing immune responses. Hum Gene Ther 2005 0.78
64 Beta cell regeneration after single-round immunological destruction in a mouse model. Diabetologia 2014 0.78
65 Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia. Hum Gene Ther 2014 0.77
66 Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors. Hum Gene Ther 2015 0.77
67 Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains. Mol Ther 2005 0.77
68 CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy. Hum Gene Ther 2014 0.77
69 Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells. J Orthop Res 2004 0.77
70 Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model. Hum Gene Ther 2011 0.76
71 Revised non-contact mapping of ventricular scar in a post-infarct ovine model with validation using contact mapping and histology. Europace 2010 0.75
72 Bone regeneration through transplantation of genetically modified cells. Clin Plast Surg 2003 0.75
73 Evaluation of noncontact mapping by comparison with simultaneous multisite contact recordings in acute ischemic ventricular fibrillation. J Cardiovasc Electrophysiol 2010 0.75
74 Simultaneous biventricular noncontact mapping and ablation of septal ventricular tachycardia in a chronic ovine infarct model. Circ Arrhythm Electrophysiol 2009 0.75
75 Common cold, uncommon variation. N Engl J Med 2009 0.75
76 Advancing aspirin utilization: a review of clinical and systems-based interventions. Am J Med Qual 2010 0.75
77 Transcatheter non-contact microwave ablation may enable circumferential renal artery denervation while sparing the vessel intima and media. EuroIntervention 2016 0.75
78 Percutaneous microwave ablation with a long side-firing antenna array can successfully treat a nonsurgical chronic ovine atrial flutter model. J Cardiovasc Electrophysiol 2009 0.75
79 Electrical impedance tomography for assessing ventilation/perfusion mismatch for pulmonary embolism detection without interruptions in respiration. Conf Proc IEEE Eng Med Biol Soc 2014 0.75
80 Generation of multivalent genome-wide T cell responses in HLA-A*0201 transgenic mice by an HIV-1 expression library immunization (ELI) vaccine. Res Initiat Treat Action 2003 0.75
81 Targeted delivery of expression plasmids to the lung via macroaggregated polyethylenimine-albumin conjugates. Methods Mol Med 2003 0.75